selenium has been researched along with Protein Aggregation, Pathological in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| León-González, ME; Madrid, Y; Romero-Sánchez, I; Rosales-Conrado, N; Vicente-Zurdo, D | 1 |
| Chen, J; Wang, N; Wang, W; Yang, L; Zheng, G | 1 |
| Huo, X; Jin, X; Li, Y; Zhang, L; Zhang, Y | 1 |
| Liu, J; Liu, Y; Sun, J; Wei, C; Xie, W; Xu, M; Zhou, H | 1 |
4 other study(ies) available for selenium and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Ability of selenium species to inhibit metal-induced Aβ aggregation involved in the development of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Copper; Humans; Iron; Metals; Nanoparticles; Protein Aggregates; Protein Aggregation, Pathological; Selenium; Zinc | 2020 |
A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Humans; Nanoparticles; PC12 Cells; Protein Aggregates; Protein Aggregation, Pathological; Rats; Reactive Oxygen Species; Resveratrol; Selenium | 2018 |
A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Curcumin; Drug Delivery Systems; Mice; Nanoparticles; Nanospheres; Plaque, Amyloid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Aggregation, Pathological; Selenium | 2019 |
Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; beta-Cyclodextrins; Blood-Brain Barrier; Camphanes; Cell Line, Tumor; Cells, Cultured; Delayed-Action Preparations; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Synergism; Humans; Mice; Nanoconjugates; Oxidation-Reduction; Porosity; Protein Aggregation, Pathological; Reactive Oxygen Species; Resveratrol; Selenium; Specific Pathogen-Free Organisms | 2019 |